Funding news · Nov 17, 2026
Aevius Labs Raises $22M Seed Led by Insight Partners for Healthcare AI Reasoning Layer
Aevius Labs Secures $22M Seed Round
Aevius Labs, a Boston-based healthcare AI company, has raised a $22 million seed round led by Insight Partners. The funding was announced on November 17, 2026.
What the Company Does
Aevius Labs is building a unified reasoning layer over longitudinal patient data, with the stated mission of making medicine computable. The company was spun out of Harvard and Mass General Brigham.
It is commercializing APOLLO, a multimodal foundation model trained on decades of hospital records to represent patients and predict clinical outcomes. The model runs inside a health system data warehouse, so protected health information stays within governed, HIPAA-compliant boundaries.
Funding Details
- Round type: Seed
- Amount: $22,000,000 USD
- Date: November 17, 2026
- Lead investor: Insight Partners
Why It Matters for Acquirers
Aevius sits at the intersection of two areas that have drawn sustained strategic interest: clinical AI and data-governed infrastructure for health systems. Its approach of deploying the model inside the health system's own data warehouse is a differentiator for buyers concerned with privacy and compliance.
The company's academic pedigree — spun out of Harvard and Mass General Brigham — and its focus on longitudinal patient data give it a foundation that could be attractive to acquirers in health IT, payer infrastructure, or clinical decision support.
Outlook
With a $22 million seed round led by Insight Partners, Aevius Labs has capital to advance commercialization of APOLLO and expand its footprint with health system partners. The company's stage and positioning make it one to watch in the healthcare AI landscape.